1. Home
  2. VIR vs VSTS Comparison

VIR vs VSTS Comparison

Compare VIR & VSTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • VSTS
  • Stock Information
  • Founded
  • VIR 2016
  • VSTS 1936
  • Country
  • VIR United States
  • VSTS United States
  • Employees
  • VIR N/A
  • VSTS N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • VSTS
  • Sector
  • VIR Health Care
  • VSTS
  • Exchange
  • VIR Nasdaq
  • VSTS Nasdaq
  • Market Cap
  • VIR 844.9M
  • VSTS 763.0M
  • IPO Year
  • VIR 2019
  • VSTS N/A
  • Fundamental
  • Price
  • VIR $5.13
  • VSTS $6.13
  • Analyst Decision
  • VIR Strong Buy
  • VSTS Hold
  • Analyst Count
  • VIR 7
  • VSTS 4
  • Target Price
  • VIR $32.86
  • VSTS $11.75
  • AVG Volume (30 Days)
  • VIR 1.1M
  • VSTS 2.8M
  • Earning Date
  • VIR 07-31-2025
  • VSTS 08-06-2025
  • Dividend Yield
  • VIR N/A
  • VSTS 1.82%
  • EPS Growth
  • VIR N/A
  • VSTS N/A
  • EPS
  • VIR N/A
  • VSTS N/A
  • Revenue
  • VIR $20,861,000.00
  • VSTS $2,731,558,000.00
  • Revenue This Year
  • VIR N/A
  • VSTS N/A
  • Revenue Next Year
  • VIR N/A
  • VSTS $0.36
  • P/E Ratio
  • VIR N/A
  • VSTS N/A
  • Revenue Growth
  • VIR N/A
  • VSTS N/A
  • 52 Week Low
  • VIR $4.32
  • VSTS $5.20
  • 52 Week High
  • VIR $14.45
  • VSTS $17.83
  • Technical
  • Relative Strength Index (RSI)
  • VIR 48.62
  • VSTS 47.44
  • Support Level
  • VIR $5.00
  • VSTS $5.62
  • Resistance Level
  • VIR $5.35
  • VSTS $6.03
  • Average True Range (ATR)
  • VIR 0.24
  • VSTS 0.21
  • MACD
  • VIR 0.02
  • VSTS 0.08
  • Stochastic Oscillator
  • VIR 31.21
  • VSTS 63.16

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About VSTS Vestis Corporation

Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.

Share on Social Networks: